It has been revealed that the loss of METTL3 lead to alternative mRNA splicing and mRNA expression changes of more than 20 genes which are involved in the TP53 signaling pathway including MDM2, and P21 in HCC (4, 35). The gene discussed is MDM2; the disease is hepatocellular carcinoma.